rs199472708
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PP3_StrongPP5
The NM_000218.3(KCNQ1):c.686G>A(p.Gly229Asp) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,459,792 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000218.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNQ1 | NM_000218.3 | c.686G>A | p.Gly229Asp | missense_variant, splice_region_variant | 5/16 | ENST00000155840.12 | NP_000209.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNQ1 | ENST00000155840.12 | c.686G>A | p.Gly229Asp | missense_variant, splice_region_variant | 5/16 | 1 | NM_000218.3 | ENSP00000155840 | P1 | |
KCNQ1 | ENST00000335475.6 | c.305G>A | p.Gly102Asp | missense_variant, splice_region_variant | 5/16 | 1 | ENSP00000334497 | |||
KCNQ1 | ENST00000496887.7 | c.425G>A | p.Gly142Asp | missense_variant, splice_region_variant | 6/16 | 5 | ENSP00000434560 | |||
KCNQ1 | ENST00000646564.2 | c.478-11420G>A | intron_variant | ENSP00000495806 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1459792Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726222
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Atrial fibrillation, familial, 3 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 2014 | - - |
KCNQ1-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego | - | This variant has been previously reported in multiple unrelated individuals with features of KCNQ1-related disorders including early-onset atrial fibrillation, borderline QT prolongation, and sudden cardiac death (PMID: 24096004, 30967788, 34076677). Functional analyses including patch-clamp studies support a gain-of-function, arrhythmogenic effect for the c.686G>A (p.Gly229Asp) variant (PMID: 24096004, 30967788). This variant is absent from the gnomAD population database and thus is presumed to be rare. It affects a highly conserved amino acid and is predicted by multiple in silico tools to have a deleterious effect on protein function. Based on the available evidence, c.686G>A (p.Gly229Asp) is classified as Pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 12, 2012 | p.Gly229Asp (GGC>GAC): c.686 G>A in exon 5 of the KCNQ1 gene (NM_000218.2). The Gly229Asp variant in the KCNQ1 gene has been reported in one individual with arrythmia and it was absent from 190 Caucasian control individuals (Ueda K et al., 2009). Additionally, the NHLBI ESP Exome Variant Server reports Gly229Asp was not observed in approximately 6,500 samples from individuals of European and African American backgrounds, indicating it is not a common benign variant in these populations. Mutations in nearby residues (Ser225Leu, Ala226Val, Arg231Cys, Arg231His) have been reported in association with LQTS, further supporting the functional importance of this region of the protein. In summary, Gly229Asp in the KCNQ1 gene is interpreted as a disease-causing mutation. The variant is found in LQT panel(s). - |
Long QT syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 26, 2020 | This variant has been reported to affect KCNQ1 protein function (PMID: 30967788, 24096004). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has been observed in individual(s) with atrial fibrillation and/or long QT syndrome (PMID: 30967788, 24096004, 19165230). ClinVar contains an entry for this variant (Variation ID: 53085). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glycine with aspartic acid at codon 229 of the KCNQ1 protein (p.Gly229Asp). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and aspartic acid. - |
Congenital long QT syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Long QT syndrome in the following publications (PMID:19165230). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at